S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:DH

Definitive Healthcare (DH) Stock Price, News & Analysis

$8.07
+0.16 (+2.02%)
(As of 03/28/2024 ET)
Today's Range
$7.88
$8.14
50-Day Range
$7.61
$10.26
52-Week Range
$5.53
$12.45
Volume
622,191 shs
Average Volume
456,828 shs
Market Capitalization
$950.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.31

Definitive Healthcare MarketRank™ Stock Analysis

Analyst Rating
Hold
2.30 Rating Score
Upside/​Downside
40.2% Upside
$11.31 Price Target
Short Interest
Healthy
10.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Definitive Healthcare in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.18%
From $0.11 to $0.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.24 out of 5 stars

Medical Sector

176th out of 939 stocks

Prepackaged Software Industry

34th out of 200 stocks

DH stock logo

About Definitive Healthcare Stock (NASDAQ:DH)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Stock Price History

DH Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Definitive Healthcare Corp Class A
DH Apr 2024 5.000 put
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
DH Jul 2024 5.000 put
What 4 Analyst Ratings Have To Say About Definitive Healthcare
Definitive Healthcare reports Q4 results
Earnings Outlook For Definitive Healthcare
DH Mar 2024 10.000 call
Definitive Healthcare just downgraded at Needham, here's why
See More Headlines
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Fax
N/A
Employees
950
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.31
High Stock Price Target
$15.00
Low Stock Price Target
$9.50
Potential Upside/Downside
+40.2%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
10 Analysts

Profitability

Net Income
$-202,390,000.00
Pretax Margin
-122.58%

Debt

Sales & Book Value

Annual Sales
$251.41 million
Cash Flow
$3.22 per share
Book Value
$10.31 per share

Miscellaneous

Free Float
99,747,000
Market Cap
$950.00 million
Optionable
Not Optionable
Beta
1.43
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Jason Ronald Krantz (Age 50)
    Founder, Executive Chairman & Interim CEO
    Comp: $820.92k
  • Mr. Jon Maack
    President
  • Mr. Richard Douglas BoothMr. Richard Douglas Booth (Age 55)
    Chief Financial Officer
    Comp: $562.44k
  • Ms. Kate Marie Shamsuddin Jensen (Age 38)
    Chief Product Officer
    Comp: $393.26k
  • Mr. Scott Oberlink
    Chief Technology Officer
  • Mr. Matt Ruderman
    Chief Legal Officer & Secretary
  • Mr. Craig Hazenfield
    Chief People Officer
  • Mr. Ram Sharma
    Executive Vice President of Life Sciences
  • Ms. Carrie Lazorchak
    Chief Revenue Officer

DH Stock Analysis - Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.
View DH analyst ratings
or view top-rated stocks.

What is Definitive Healthcare's stock price target for 2024?

10 brokers have issued 1-year price objectives for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they anticipate the company's stock price to reach $11.31 in the next twelve months. This suggests a possible upside of 40.2% from the stock's current price.
View analysts price targets for DH
or view top-rated stocks among Wall Street analysts.

How have DH shares performed in 2024?

Definitive Healthcare's stock was trading at $9.94 at the beginning of the year. Since then, DH stock has decreased by 18.8% and is now trading at $8.07.
View the best growth stocks for 2024 here
.

Are investors shorting Definitive Healthcare?

Definitive Healthcare saw a decline in short interest in March. As of March 15th, there was short interest totaling 4,830,000 shares, a decline of 35.3% from the February 29th total of 7,470,000 shares. Based on an average daily trading volume, of 572,300 shares, the days-to-cover ratio is presently 8.4 days. Currently, 10.2% of the shares of the company are sold short.
View Definitive Healthcare's Short Interest
.

When is Definitive Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our DH earnings forecast
.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) released its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by $0.02. The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive trailing twelve-month return on equity of 0.43%.

What ETFs hold Definitive Healthcare's stock?
What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare issued an update on its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of 0.070-0.080 for the period, compared to the consensus estimate of 0.070. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $65.7 million.

When did Definitive Healthcare IPO?

Definitive Healthcare (DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share.

Who are Definitive Healthcare's major shareholders?

Definitive Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (4.75%), Vanguard Group Inc. (3.84%), Vanguard Group Inc. (3.80%), Brown Advisory Inc. (3.38%), Massachusetts Financial Services Co. MA (2.98%) and Riverbridge Partners LLC (1.52%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends
.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners